Which ASX ETFs hold Arrowhead Pharmaceuticals Inc (ARWR)?
As at Q3 2026, ARWR is among the most widely held stocks across ASX-listed ETFs, appearing in approximately 6 ETFs. Its largest single position is approximately 2.85% in HLTH (VanEck Global Healthcare Leaders ETF). General information only, not financial advice.
General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
All weights are approximate, drawn from each fund's published holdings as at Q3 2026, and change as funds rebalance.
| ETF | Fund | Category | Weight |
|---|---|---|---|
| HLTH | VanEck Global Healthcare Leaders ETF | Thematic | approx. 2.85% |
| CURE | Global X S&P Biotech ETF | Thematic | approx. 1.11% |
| QSML | VanEck MSCI International Small Companies Quality ETF | Thematic | approx. 0.72% |
| QHSM | VanEck MSCI International Small Companies Quality (AUD Hedged) ETF | Thematic | approx. 0.71% |
| VISM | Vanguard MSCI International Small Companies Index ETF | Global Broad Market | approx. 0.10% |
| VTS | Vanguard US Total Market Shares Index ETF | US Shares | approx. 0.02% |
Want to see what any of these funds overlap with? Try the free ETF overlap checker, or browse the most widely held stocks.
Hold more than one of these? See your combined ARWR exposure across all your ETFs with the Stock X-Ray.
ARWR in ETFs: frequently asked questions
Which ASX ETFs hold ARWR?
Arrowhead Pharmaceuticals Inc (ARWR) is held by approximately 6 ASX-listed ETFs, including HLTH, CURE, QSML, QHSM, VISM. General information only.
Which ETF has the largest ARWR weighting?
HLTH (VanEck Global Healthcare Leaders ETF) has the largest ARWR position at approximately 2.85% of the fund, as at Q3 2026. Past weightings are not a reliable indicator of future weightings.